Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

PURPOSE: To evaluate the impact of two different intraperitoneal (IP) chemotherapy regimens on progression-free survival (PFS) among women with newly diagnosed advanced ovarian carcinoma. METHODS: Eligible patients were randomly assigned to six cycles of IV paclitaxel 80 mg/m(2) once per week with i...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Oncol
Главные авторы: Walker, Joan L., Brady, Mark F., Wenzel, Lari, Fleming, Gini F., Huang, Helen Q., DiSilvestro, Paul A., Fujiwara, Keiichi, Alberts, David S., Zheng, Wenxin, Tewari, Krishnansu S., Cohn, David E., Powell, Matthew A., Van Le, Linda, Davidson, Susan A., Gray, Heidi J., Rose, Peter G., Aghajanian, Carol, Myers, Tashanna, Alvarez Secord, Angeles, Rubin, Stephen C., Mannel, Robert S.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Clinical Oncology 2019
Предметы:
ORIGINAL REPORTS
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544459/
https://ncbi.nlm.nih.gov/pubmed/31002578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.01568
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы